Merkel cell carcinoma: A clinicopathologic study with prognostic implications

Journal of Cutaneous Pathology

Volumn 31, Issue 3, 2004, Pages 217-223

  Mott, Ryan T ^a,d   Smoller, Bruce R ^b   Morgan, Michael B ^c  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN 20; NERVE CELL ADHESION MOLECULE;

ADULT; AGE DETERMINATION; AGED; ARTICLE; BLOOD VESSEL INJURY; CANCER GROWTH; CANCER INVASION; CANCER RECURRENCE; CANCER SURVIVAL; CELL ADHESION; CLINICAL ARTICLE; CLINICAL EXAMINATION; CLINICAL FEATURE; CORRELATION ANALYSIS; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LOGISTIC REGRESSION ANALYSIS; LYMPH NODE METASTASIS; LYMPHOCYTIC INFILTRATION; MALE; MERKEL CELL TUMOR; MITOSIS RATE; NERVE CELL; OUTCOMES RESEARCH; PERINEURIUM; PROGNOSIS; PROTEIN EXPRESSION; RACE DIFFERENCE; SEX DIFFERENCE; SOLID TUMOR; STATISTICAL MODEL; STATISTICAL SIGNIFICANCE; SUBCUTANEOUS TISSUE; TISSUE NECROSIS; TUMOR LOCALIZATION; TUMOR NECROSIS; TUMOR VOLUME; ULCER;

AGED; AGED, 80 AND OVER; CARCINOMA, MERKEL CELL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTERMEDIATE FILAMENT PROTEINS; KERATIN-20; LYMPHATIC METASTASIS; LYMPHOCYTES, TUMOR-INFILTRATING; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEURAL CELL ADHESION MOLECULES; PROGNOSIS; REGRESSION ANALYSIS; SKIN NEOPLASMS; SURVIVAL RATE;

EID: 1242270488     PISSN: 03036987     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0303-6987.2004.00149.x     Document Type: Article

References (27)

1. Ratner D, Nelson BR, Brown MD, Johnson TM. Merkel cell carcinoma. J Am Acad Dermatol 1993; 29: 143.
2. Silva EG, Mackay B, Goepfert H, Burgess MA, Fields RS. Endocrine carcinoma of the skin (Merkel cell carcinoma). Pathol Annu 1984; 19 (Part 2): 1.
3. Hitchcock CL, Bland KI, Laney RG III, Franzini D, Harris B, Copeland EM III. Neuroendocrine (Merkel cell) carcinoma of the skin. Its Natural History, Diagnosis, Treatment. Ann Surg 1988; 207: 201.
4. Kokoska ER, Kokoska MS, Collins BT, Stapleton DR, Wade TP. Early aggressive treatment for Merkel cell carcinoma improves outcome. Am J Surg 1997; 174: 688.
5. Sibley RK, Dehner LP, Rosai J. Primary neuroendocrine (Merkel cell?) carcinoma of the skin. I. A clinicopathologic and ultrastructural study of 43 cases. Am J Surg Pathol 1985; 9: 95.
6. Smith KJ, Skelton HG III, Holland TT, Morgan AM, Lupton GP. Neuroendocrine (Merkel cell) Carcinoma with Intraepidermal Component. Am J Dermatopathol 1993; 15: 528.
7. Pilotti S, Rilke F, Bartoli C, Grisotti A. Clinicopathologic correlations of cutaneous neuroendocrine Merkel cell carcinoma. J Clin Oncol 1988; 6: 1863.
8. Warner TF, Uno H, Hafez GR, et al. Merkel cells and Merkel cell tumors. Ultrastructure, immunocytochemistry and review of the literature. Cancer 1983; 52: 238.
9. Chan JK, Suster S, Wenig BM, Tsang WY, Chan JB, Lau AI. Cytokeratin 20 immunoreactivity distinguishes Merkel cell (primary cutaneous neuroendocrine) carcinomas and salivary gland small cell carcinomas from small cell carcinomas of various sites. Am J Surg Pathol 1997; 21: 226.
10. Leong AS, Phillips GE, Pieterse AS, Milios J. Criteria for the diagnosis of primary endocrine carcinoma of the skin (Merkel cell carcinoma). A histological, immunohistochemical and ultrastructural study of 13 cases. Pathology 1986; 18: 393.
11. Miettinen M. Synaptophysin and neurofilament proteins as markers for neuroendocrine tumors. Arch Pathol Lab Med 1987; 111: 813.
12. Visscher D, Cooper PH, Zarbo RJ, Crissman JD. Cutaneous neuroendocrine (Merkel cell) carcinoma: an immunophenotypic, clinicopathologic, and flow cytometric study. Mod Pathol 1989; 2: 331.
13. Eich HT, Eich D, Staar S, et al. Role of postoperative radiotherapy in the management of Merkel cell carcinoma. Am J Clin Oncol 2002; 25: 50.
14. Coit DG. Merkel cell carcinoma. Ann Surg Oncol 2001; 8: 99S.
15. Medina-Franco H, Urist MM, Fiveash J, Heslin MJ, Bland KI, Beenken SW. Multimodality treatment of Merkel cell carcinoma: case series and literature review of 1024 cases. Ann Surg Oncol 2001; 8: 204.
16. Gillenwater AM, Hessel AC, Morrison WH, et al. Merkel cell carcinoma of the head and neck: effect of surgical excision and radiation on recurrence and survival. Arch Otolaryngol Head Neck Surg 2001; 127: 149.
17. Skelton HG, Smith KJ, Hitchcock CL, McCarthy WF, Lupton Gp, Graham JH. Merkel cell carcinoma, analysis of clinical, histologic, and immunohistologic features of 132 cases with relation to survival. J Am Acad Dermatol 1997; 37: 734.
18. Breslow A. Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg 1970; 172: 902.
19. Wanebo HJ, Woodruff J, Fortner JG. Malignant melanoma of the extremities: a clinicopathologic study using levels of invasion (microstage). Cancer 1975; 35: 666.
20. Breuninger H, Black B, Rassner G. Microstaging of squamous cell carcinomas. Am J Clin Pathol 1990; 94: 624.
21. Friedman HI, Cooper PH, Wanebo HJ. Prognostic and therapeutic use of microstaging of cutaneous squamous cell carcinoma of the trunk and extremities. Cancer 1985; 56: 1099.
22. Clemente CG, Mihm MC Jr, Bufalino R, Zurrida S, Collini P, Cascinelli N. Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma. Cancer 1996; 77: 1303.
23. Baldwin TJ, Fazeli MS, Doherty P, Walsh FS. Elucidation of the molecular actions of NCAM and structurally related cell adhesion molecules. J Cell Biochem 1996; 61: 502.
24. Crossin KL, Krushel LA. Cellular signaling by neural cell adhesion molecules of the immunoglobulin superfamily. Dev Dyn 2000; 218: 260.
25. Michalides R, Kwa B, Springall D, et al. NCAM and lung cancer. Int J Cancer Suppl 1994; 8: 34.
26. Kaiser U, Oldenburg M, Jaques G, Auerbach B, Havemann K. Soluble CD56 (NCAM): a new differential-diagnostic and prognostic marker in multiple myeloma. Ann Hematol 1996; 73: 121.
27. Miyahara R, Tanaka F, Nakagawa T, Matsuoka K, Isii K, Wada H. Expression of neural cell adhesion molecules (polysialylated form of neural cell adhesion molecule and L1-cell adhesion molecule) on resected small cell lung cancer specimens: in relation to proliferation state. J Surg Oncol 2001; 77: 49.